Isoray Announces Second Quarter Fiscal 2019 Financial Results
Revenue for the second quarter of fiscal 2019 grew 24% to a record $1.90 million versus $1.54 million in the prior year comparable period.
- Home
- About
- Brachytherapy
Patient Information
Clinician Information
Cesium 131 Products
- Theranostics
- Newsroom
- Investor Center
- Contact us
